Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Insulin Glargine Plus Continuous Intravenous Insulin for Diabetic Ketoacidosis
TCTR20200710006Phase 3Completed
- Sponsor
- N/A
- Start
- May 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of insulin glargine in diabetic ketoacidosis (DKA), sponsored by N/A. Started May 2020; status: completed.
02
Drugs
insulin glargine
03
Conditions
diabetic ketoacidosis (DKA)
Beyond the preview
Go deeper on TCTR20200710006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200710006.